(Finance) – With reference to thepublic takeover offer (OPA) fully voluntary, concerning a maximum of 1,362,500 ordinary shares of Shedir Pharmaa group listed on Euronext Growth Milan and active in the field of nutraceuticals and pharmaceuticals, Dimainvest has announced that it has communicated to the company that it has deposited the sum equal to the Total Consideration, i.e. 1,066,191 euros, restricted
to the payment of the consideration for the remaining 217,590 company shares, equal to 1.904% of the Issuer’s share capital still in circulation.
The transfer was therefore completed actions residues to Dimainvest and, consequently, Shedir Pharma will make the necessary entries in its shareholders’ register. The holders of the remaining shares will be able to obtain payment of the fee for the Joint Procedure – equal to 4.90 euros for each residual share – directly from the respective intermediaries.
Borsa Italiana has ordered the exclusion of Shedir Pharma shares from today negotiations on Euronext Growth Milan.